0001019056-19-000184.txt : 20190304
0001019056-19-000184.hdr.sgml : 20190304
20190304210919
ACCESSION NUMBER: 0001019056-19-000184
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190304
DATE AS OF CHANGE: 20190304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stromatt Scott C
CENTRAL INDEX KEY: 0001679975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 19656375
MAIL ADDRESS:
STREET 1: 2401 4TH AVENUE
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
stromatt.xml
X0306
4
2019-02-28
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001679975
Stromatt Scott C
2401 4TH AVENUE
SUITE 1050
SEATTLE
WA
98121
0
1
0
0
Chief Medical Officer and SVP
Common Stock
2019-03-01
4
M
0
16269
A
221006
D
Common Stock
2019-03-01
4
F
0
4823
1.57
D
216183
D
Stock Option (right to buy)
1.52
2019-02-28
4
A
0
67400
0
A
2029-02-28
Common Stock
67400
67400
D
Restricted Stock Unit
2019-03-01
4
M
0
16269
0
D
Common Stock
16269
0
D
Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis.
The option vests in three approximately equal annual installments beginning on February 28, 2020.
The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vested in three equal annual installments beginning on the anniversary of the grant date.
/s/ Carl A. Valenstein, attorney-in-fact
2019-03-04